Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SERA PROGNOSTICS, INC. | Director | Class A Common Stock | 43.8K | $147K | $3.35 | Apr 7, 2025 | Direct |
Karyopharm Therapeutics Inc. | Director | Nonstatutory Stock Option (right to buy) | 69K | May 29, 2024 | Direct | ||
SERA PROGNOSTICS, INC. | Director | Stock Option (right to buy) | 0 | Jan 27, 2025 | Direct |